Next Level Commerce: Staying Up on Fraud Prevention through Pandemic-Inspired Innovation

The COVID-19 pandemic was a challenge for retailers, but many of them rose to the occasion with solutions that made it possible to keep running their business while keeping their employees and customers safe.

Unfortunately, where there is commerce, there will almost always be crime, and the pandemic gave fraudsters other avenues to pursue, said Rich Stuppy, Vice President & Senior Customer Experience Leader at Kount, an Equifax Company. Some businesses were already up and running with the necessary fraud protection, but many who adapted quickly haven’t had their security system catch up.

“Those that were relatively new to it and had, let’s say, a toe in the water. They had to move forward quickly as a matter of survival, and they hadn’t plumbed in the controls, the signal detection, the things you need to do to protect yourself from fraud and cyber security events in this digital space,” he said. “So, they learned some very painful lessons and learned them quickly. I think because of the never-ending game of cat and mouse that happens in fraud, fraud control, criminals and cyber security, you’re never ‘there.’ You’re always on the journey and getting a harder, stronger, tougher target.”

One of the best things to consider when thinking about fraud and risk needs is mapping out a customer journey, Stuppy said.

“When you think about it in terms of the journey, and you’re balancing customer experience with fraud and cyber security, that’s a completely different story than, ‘I’m rolling out a product, and I’m going to see what happens,’” he said. “Because, I can guarantee you, the fraudsters and the organized criminals are looking for those new changes, and they’re going to probe those new changes. You might not think there’s a lot of value in there, but they have an excellent methodology for testing those customer journey steps and finding the places that don’t have the controls and signal collection.”

Kount’s robust solutions for payment protection and protection around fraud, risk and loss made it an ideal partner for FreedomPay, especially with the ability to scale to work with the smallest ecommerce operator up to some of the largest corporations in the world.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More